Based on the information provided, there is a potential connection between rheumatoid arthritis (RA) and bilateral plantar fibromas. Here are some key points to consider:
Key Findings from the Ultrasound (October 30)
- Mild avascular synovial thickening in the 2nd-4th MTP joints bilaterally
- No active synovitis detected. Show Full Answer
Based on the information provided, there is a potential connection between rheumatoid arthritis (RA) and bilateral plantar fibromas. Here are some key points to consider:
Key Findings from the Ultrasound (October 30):
- Mild avascular synovial thickening in the 2nd-4th MTP joints bilaterally.
- No active synovitis detected.
- Suspected left tibiotalar and anterior talofibular ligamentous strain.
- Thickening of the right plantar fascia with a suspected small intrasubstance tear.
- Bilateral plantar fibromas.
Considerations:
- Plantar Fasciitis vs. Plantar Fibromas:
- Plantar fasciitis involves inflammation of the plantar fascia, often causing heel pain.
- Plantar fibromas are benign growths in the plantar fascia, which can be mistaken for plantar fasciitis due to similar symptoms.
- RA and Foot Involvement:
- RA can cause synovial thickening and joint issues in the feet, which might contribute to or exacerbate conditions like plantar fasciitis or fibromas.
Next Steps:
- Consult Your Rheumatologist:
- Discuss the ultrasound findings, especially the presence of bilateral plantar fibromas and the thickening of the plantar fascia.
- Consider whether the initial diagnosis of plantar fasciitis might need to be revisited in light of the new findings.
- Treatment Adjustments:
- Review the effectiveness of current treatments (orthotics, shockwave therapy) and explore additional options if symptoms persist or worsen.
Time Awareness:
- The ultrasound was done on October 30, and today is November 7, 2024. Ensure to bring up these recent findings in your upcoming rheumatologist appointment on December 20.
This detailed approach will help you address your concerns effectively with your healthcare provider.
November 6, 2024